Dacorin for Proliferative Vitreoretinopathy
NCT02865031
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
PVR
Interventions
DRUG:
Decorin
Sponsor
Cairo University